NCT01807871 arm group e4f99da39de155ae4a8aef37138038a0 [clinicaltrials_resource:NCT01807871/arm-group/e4f99da39de155ae4a8aef37138038a0]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01807871 arm group e4f99da39de155ae4a8aef37138038a0 [clinicaltrials_resource:NCT01807871/arm-group/e4f99da39de155ae4a8aef37138038a0]
Bio2RDF identifier
NCT01807871/arm-group/e4f99da39de155ae4a8aef37138038a0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... f99da39de155ae4a8aef37138038a0
description [clinicaltrials_vocabulary:description]
Participants will continue to ...... than 75% of pre study levels.
identifier
clinicaltrials_resource:NCT01807871/arm-group/e4f99da39de155ae4a8aef37138038a0
title
NCT01807871 arm group e4f99da39de155ae4a8aef37138038a0
@en
type
label
NCT01807871 arm group e4f99da3 ...... 99da39de155ae4a8aef37138038a0]
@en